{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:19:47Z","timestamp":1789438787041,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Depression and fatigue are common in breast cancer survivors, and their presence is associated with personal suffering and worse prognosis. While many women receive short-term psychological support in the acute treatment phase, this is rarely available in subsequent phases. Internet interventions for breast cancer survivors could provide additional psychological support, as they are easily accessible and may be effective. However, no trial has yet examined the effectiveness of an Internet intervention that provides cognitive behavioural therapy techniques plus lifestyle advice for this population. This trial aims to test whether<jats:italic>Optimune<\/jats:italic>, a novel Internet intervention we developed for that purpose, leads to improvements in quality of life and relevant lifestyle habits over the course of 3 to 6 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This randomized controlled trial (RCT) will include 360 female breast cancer survivors who have completed the active tumour eradication phase. Participants will be recruited from various settings, including web-based advertisements and Internet forums in German-speaking countries. The main inclusion criteria are a breast cancer diagnosis less than 5\u2009years ago and completion of acute treatment at least 1\u2009month ago, as verified by discharge letter from an oncology treatment centre. Participants will be randomly assigned to either (1) a control group, in which they receive care as usual (CAU) and are given access to<jats:italic>Optimune<\/jats:italic>after a delay of 3\u2009months (CAU\/wait list control), or (2) a treatment group that may also use CAU and will receive 12-month access to<jats:italic>Optimune<\/jats:italic>immediately after randomization. The three primary endpoints are quality of life, physical activity and diet quality, assessed with the World Health Organization Quality of Life Questionnaire, the International Physical Activity Questionnaire and the Food Quality Questionnaire, at 3 months post-baseline; secondary outcomes include cancer-related fatigue, emotional stress, depression, anxiety, fear of progression, insomnia, usefulness of the programme and negative treatment effects. Online assessments are conducted at baseline (T0), 3 months (T1) and 6 months (T2).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Results of this RCT are expected to extend the body of knowledge with regard to the effectiveness of CBT-based Internet interventions for female breast cancer survivors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>ClinicalTrials.gov,<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03643640\">NCT03643640<\/jats:ext-link>. Registered on 23 August 2018.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13063-019-3987-y","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T18:03:15Z","timestamp":1580320995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Protocol for the Optimune trial: a randomized controlled trial evaluating a novel Internet intervention for breast cancer survivors"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5155-7963","authenticated-orcid":false,"given":"Franziska","family":"Holtdirk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Mehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Watzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"key":"3987_CR1","unstructured":"Robert Koch-Institut. Brustkrebs (Mammakarzinom). 2017. https:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Krebsarten\/Brustkrebs\/brustkrebs_node.html. Accessed 12 Mar 2019."},{"key":"3987_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"3987_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1055\/s-0033-1355476","volume":"10","author":"R Kreienberg","year":"2013","unstructured":"Kreienberg R, Albert U, Follmann M, Kopp I, K\u00fchn T, W\u00f6ckel A. Interdisziplin\u00e4re S3-Leitlinie f\u00fcr die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. Senologie - Zeitschrift f\u00fcr Mammadiagnostik und -therapie. 2013;10:164\u201392.","journal-title":"Senologie - Zeitschrift f\u00fcr Mammadiagnostik und -therapie"},{"key":"3987_CR4","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/annonc\/mdw099","volume":"27","author":"HJG Abrahams","year":"2016","unstructured":"Abrahams HJG, Gielissen MFM, Schmits IC, Verhagen CAHHVM, Rovers MM, Knoop H. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol. 2016;27:965\u201374.","journal-title":"Ann Oncol"},{"key":"3987_CR5","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/cncr.21671","volume":"106","author":"JE Bower","year":"2006","unstructured":"Bower JE, Ganz PA, Desmond KA, Bernaards C, Rowland JH, Meyerowitz BE, et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006;106:751\u20138.","journal-title":"Cancer."},{"key":"3987_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.maturitas.2015.04.010","volume":"82","author":"SWMC Maass","year":"2015","unstructured":"Maass SWMC, Roorda C, Berendsen AJ, Verhaak PFM, de Bock GH. The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: a systematic review. Maturitas. 2015;82:100\u20138.","journal-title":"Maturitas."},{"key":"3987_CR7","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1365-2648.2007.04563.x","volume":"61","author":"D Von Ah","year":"2008","unstructured":"Von Ah D, Kang D-H. Correlates of mood disturbance in women with breast cancer: patterns over time. J Adv Nurs. 2008;61:676\u201389.","journal-title":"J Adv Nurs"},{"key":"3987_CR8","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/00006842-200207000-00010","volume":"64","author":"JE Bower","year":"2002","unstructured":"Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002;64:604\u201311.","journal-title":"Psychosom Med"},{"key":"3987_CR9","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1158\/1078-0432.CCR-05-2398","volume":"12","author":"A Collado-Hidalgo","year":"2006","unstructured":"Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res. 2006;12:2759\u201366.","journal-title":"Clin Cancer Res"},{"key":"3987_CR10","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1200\/JCO.2008.18.9068","volume":"27","author":"BL Pierce","year":"2009","unstructured":"Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol. 2009;27:3437\u201344.","journal-title":"J Clin Oncol"},{"key":"3987_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446\u201357.","journal-title":"Biol Psychiatry"},{"key":"3987_CR12","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/pon.4048","volume":"25","author":"S Sanjida","year":"2016","unstructured":"Sanjida S, Janda M, Kissane D, Shaw J, Pearson S-A, DiSipio T, et al. A systematic review and meta-analysis of prescribing practices of antidepressants in cancer patients. Psychooncology. 2016;25:1002\u201316.","journal-title":"Psychooncology."},{"key":"3987_CR13","doi-asserted-by":"publisher","first-page":"i5309","DOI":"10.1136\/bmj.i5309","volume":"354","author":"D Juurlink","year":"2016","unstructured":"Juurlink D. Revisiting the drug interaction between tamoxifen and SSRI antidepressants. BMJ. 2016;354:i5309.","journal-title":"BMJ."},{"key":"3987_CR14","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, DellaGioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology. 2011;36:2452\u20139.","journal-title":"Neuropsychopharmacology."},{"key":"3987_CR15","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","volume":"71","author":"O K\u00f6hler","year":"2014","unstructured":"K\u00f6hler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry. 2014;71:1381\u201391.","journal-title":"JAMA Psychiatry."},{"key":"3987_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70:31\u201341.","journal-title":"JAMA Psychiatry"},{"key":"3987_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jpsychires.2016.01.008","volume":"75","author":"G Del Grande da Silva","year":"2016","unstructured":"Del Grande da Silva G, Wiener CD, Barbosa LP, Gon\u00e7alves Araujo JM, Molina ML, San Martin P, et al. Pro-inflammatory cytokines and psychotherapy in depression: results from a randomized clinical trial. J Psychiatr Res. 2016;75:57\u201364.","journal-title":"J Psychiatr Res"},{"key":"3987_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jneuroim.2015.06.004","volume":"285","author":"FP Moreira","year":"2015","unstructured":"Moreira FP, de Azevedo Cardoso T, Mondin TC, de Mattos Souza LD, Silva R, Jansen K, et al. The effect of proinflammatory cytokines in Cognitive Behavioral Therapy. J Neuroimmunol. 2015;285:143\u20136.","journal-title":"J Neuroimmunol"},{"key":"3987_CR19","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1037\/ccp0000122","volume":"84","author":"E Walsh","year":"2016","unstructured":"Walsh E, Eisenlohr-Moul T, Baer R. Brief mindfulness training reduces salivary IL-6 and TNF-\u03b1 in young women with depressive symptomatology. J Consult Clin Psychol. 2016;84:887\u201397.","journal-title":"J Consult Clin Psychol"},{"key":"3987_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/nyas.12998","volume":"1373","author":"DS Black","year":"2016","unstructured":"Black DS, Slavich GM. Mindfulness meditation and the immune system: a systematic review of randomized controlled trials. Ann N Y Acad Sci. 2016;1373:13\u201324.","journal-title":"Ann N Y Acad Sci"},{"key":"3987_CR21","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1200\/JCO.2013.51.8860","volume":"32","author":"JK Kiecolt-Glaser","year":"2014","unstructured":"Kiecolt-Glaser JK, Bennett JM, Andridge R, Peng J, Shapiro CL, Malarkey WB, et al. Yoga\u2019s impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2014;32:1040\u20139.","journal-title":"J Clin Oncol"},{"key":"3987_CR22","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/cncr.29194","volume":"121","author":"JE Bower","year":"2015","unstructured":"Bower JE, Crosswell AD, Stanton AL, Crespi CM, Winston D, Arevalo J, et al. Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial. Cancer. 2015;121:1231\u201340.","journal-title":"Cancer."},{"key":"3987_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01.PSY.0000074003.35911.41","volume":"65","author":"LE Carlson","year":"2003","unstructured":"Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosomatic Medicine. 2003;65:571\u201381.","journal-title":"Psychosomatic Medicine"},{"key":"3987_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bbi.2008.08.002","volume":"23","author":"BA McGregor","year":"2009","unstructured":"McGregor BA, Antoni MH. Psychological intervention and health outcomes among women treated for breast cancer: a review of stress pathways and biological mediators. Brain Behav Immun. 2009;23:159\u201366.","journal-title":"Brain Behav Immun"},{"key":"3987_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/YCO.0000000000000121","volume":"28","author":"P Cuijpers","year":"2015","unstructured":"Cuijpers P. Psychotherapies for adult depression: recent developments. Current Opinion in Psychiatry. 2015;28:24\u20139.","journal-title":"Current Opinion in Psychiatry"},{"key":"3987_CR26","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1634\/theoncologist.2016-0245","volume":"22","author":"V Zimmermann-Schlegel","year":"2017","unstructured":"Zimmermann-Schlegel V, Hartmann M, Sklenarova H, Herzog W, Haun MW. Accessibility, availability, and potential benefits of psycho-oncology services: the perspective of community-based physicians providing cancer survivorship care. Oncologist. 2017;22:719\u201327.","journal-title":"Oncologist."},{"key":"3987_CR27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jclp.20659","volume":"66","author":"DC Mohr","year":"2010","unstructured":"Mohr DC, Ho J, Duffecy J, Baron KG, Lehman KA, Jin L, et al. Perceived barriers to psychological treatments and their relationship to depression. J Clin Psychol. 2010;66:394\u2013409.","journal-title":"J Clin Psychol"},{"key":"3987_CR28","unstructured":"Leitlinienprogramm Onkologie. Psychoonkologische Diagnostik, Beratung und Behandlung von erwachsenen Krebspatienten. 2014. https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Psychoonkologieleitlinie_1.1\/LL_PSO_Langversion_1.1.pdf. Accessed 7 Mar 2019."},{"key":"3987_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/caac.21319","volume":"66","author":"CD Runowicz","year":"2016","unstructured":"Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American Cancer Society\/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin. 2016;66:43\u201373.","journal-title":"CA Cancer J Clin"},{"key":"3987_CR30","volume-title":"Improving outcomes in breast cancer: manual update","author":"National Institute for Clinical Excellence","year":"2002","unstructured":"National Institute for Clinical Excellence. Improving outcomes in breast cancer: manual update. London: National Institute for Clinical Excellence; 2002."},{"key":"3987_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/1745691610393527","volume":"6","author":"AE Kazdin","year":"2011","unstructured":"Kazdin AE, Blase SL. Rebooting psychotherapy research and practice to reduce the burden of mental illness. Perspect Psychol Sci. 2011;6:21\u201337.","journal-title":"Perspect Psychol Sci"},{"key":"3987_CR32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1037\/ccp0000171","volume":"85","author":"CG Beevers","year":"2017","unstructured":"Beevers CG, Pearson R, Hoffman JS, Foulser AA, Shumake J, Meyer B. Effectiveness of an internet intervention (Deprexis) for depression in a United States adult sample: a parallel-group pragmatic randomized controlled trial. J Consult Clin Psychol. 2017;85:367\u201380.","journal-title":"J Consult Clin Psychol"},{"key":"3987_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/16506073.2011.616531","volume":"40","author":"T Berger","year":"2011","unstructured":"Berger T, H\u00e4mmerli K, Gubser N, Andersson G, Caspar F. Internet-based treatment of depression: a randomized controlled trial comparing guided with unguided self-help. Cogn Behav Ther. 2011;40:251\u201366.","journal-title":"Cogn Behav Ther"},{"key":"3987_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1017\/S0033291716002270","volume":"47","author":"T Berger","year":"2017","unstructured":"Berger T, Urech A, Krieger T, Stolz T, Schulz A, Vincent A, et al. Effects of a transdiagnostic unguided Internet intervention ('velibra\u2019) for anxiety disorders in primary care: results of a randomized controlled trial. Psychol Med. 2017;47:67\u201380.","journal-title":"Psychol Med"},{"key":"3987_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S2215-0366(14)00049-2","volume":"2","author":"A Fischer","year":"2015","unstructured":"Fischer A, Schr\u00f6der J, Vettorazzi E, Wolf OT, P\u00f6ttgen J, Lau S, et al. An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial. Lancet Psychiatry. 2015;2:217\u201323.","journal-title":"Lancet Psychiatry"},{"key":"3987_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1055\/s-0043-122241","volume":"68","author":"K Fuhr","year":"2018","unstructured":"Fuhr K, Fahse B, Hautzinger M, Gulewitsch M. Erste Erfahrungen zur Implementierbarkeit einer internet-basierten Selbsthilfe zur \u00dcberbr\u00fcckung der Wartezeit auf eine ambulante Psychotherapie. PPmP - Psychother Psych Med Psych. 2018;68:234\u201341.","journal-title":"PPmP - Psychother Psych Med Psych"},{"key":"3987_CR37","doi-asserted-by":"publisher","first-page":"A714","DOI":"10.1016\/j.jval.2017.08.1893","volume":"20","author":"V Gr\u00e4fe","year":"2017","unstructured":"Gr\u00e4fe V, Greiner W. Internet based treatment of depressive symptoms \u2014 a health economic evaluation of costs and benefits. Value Health. 2017;20:A714.","journal-title":"Value Health"},{"key":"3987_CR38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000445355","volume":"85","author":"JP Klein","year":"2016","unstructured":"Klein JP, Berger T, Schr\u00f6der J, Sp\u00e4th C, Meyer B, Caspar F, et al. Effects of a psychological internet intervention in the treatment of mild to moderate depressive symptoms: results of the evident study, a randomized controlled trial. Psychother Psychosom. 2016;85:218\u201328.","journal-title":"Psychother Psychosom"},{"key":"3987_CR39","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.1151","volume":"11","author":"B Meyer","year":"2009","unstructured":"Meyer B, Berger T, Caspar F, Beevers CG, Andersson G, Weiss M. Effectiveness of a novel integrative online treatment for depression (Deprexis): randomized controlled trial. J Med Internet Res. 2009;11:e15.","journal-title":"J Med Internet Res"},{"key":"3987_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.invent.2014.12.003","volume":"2","author":"B Meyer","year":"2015","unstructured":"Meyer B, Bierbrodt J, Schr\u00f6der J, Berger T, Beevers CG, Weiss M, et al. Effects of an Internet intervention (Deprexis) on severe depression symptoms: randomized controlled trial. Internet Interv. 2015;2:48\u201359.","journal-title":"Internet Interv"},{"key":"3987_CR41","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.brat.2012.04.006","volume":"50","author":"S Moritz","year":"2012","unstructured":"Moritz S, Schilling L, Hauschildt M, Schr\u00f6der J, Treszl A. A randomized controlled trial of internet-based therapy in depression. Behav Res Ther. 2012;50:513\u201321.","journal-title":"Behav Res Ther"},{"key":"3987_CR42","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1111\/epi.12833","volume":"55","author":"J Schr\u00f6der","year":"2014","unstructured":"Schr\u00f6der J, Br\u00fcckner K, Fischer A, Lindenau M, K\u00f6ther U, Vettorazzi E, et al. Efficacy of a psychological online intervention for depression in people with epilepsy: a randomized controlled trial. Epilepsia. 2014;55:2069\u201376.","journal-title":"Epilepsia."},{"key":"3987_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1159\/000481177","volume":"86","author":"R Zwerenz","year":"2017","unstructured":"Zwerenz R, Becker J, Knickenberg RJ, Siepmann M, Hagen K, Beutel ME. Online self-help as an add-on to inpatient psychotherapy: efficacy of a new blended treatment approach. Psychother Psychosom. 2017;86:341\u201350.","journal-title":"Psychother Psychosom"},{"key":"3987_CR44","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.psychres.2017.06.081","volume":"256","author":"C Twomey","year":"2017","unstructured":"Twomey C, O\u2019Reilly G, Meyer B. Effectiveness of an individually-tailored computerised CBT programme (Deprexis) for depression: a meta-analysis. Psychiatry Res. 2017;256:371\u20137.","journal-title":"Psychiatry Res"},{"issue":"4","key":"3987_CR45","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/epi.14673","volume":"60","author":"Bj\u00f6rn Meyer","year":"2019","unstructured":"Meyer B, Weiss M, Holtkamp M, Arnold S, Br\u00fcckner K, Schr\u00f6der J, et al. Effects of an epilepsy-specific Internet intervention (Emyna) on depression: results of the ENCODE randomized controlled trial. Epilepsia. 2019;60:656\u201368.","journal-title":"Epilepsia"},{"key":"3987_CR46","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/jnnp-2017-317463","volume":"89","author":"J P\u00f6ttgen","year":"2018","unstructured":"P\u00f6ttgen J, Moss-Morris R, Wendebourg J-M, Feddersen L, Lau S, K\u00f6pke S, et al. Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2018;89:970\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3987_CR47","doi-asserted-by":"publisher","unstructured":"Zill JM, Christalle E, Meyer B, H\u00e4rter M, Dirmaier J. The effectiveness of an internet intervention aimed at reducing alcohol consumption in adults. Deutsches Aerzteblatt Online. 2019. https:\/\/doi.org\/10.3238\/arztebl.2019.0127.","DOI":"10.3238\/arztebl.2019.0127"},{"key":"3987_CR48","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1192\/apt.8.5.326","volume":"8","author":"M Hotopf","year":"2002","unstructured":"Hotopf M. The pragmatic randomised controlled trial. Adv Psychiatr Treat. 2002;8:326\u201333.","journal-title":"Adv Psychiatr Treat"},{"key":"3987_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/ebm.14.4.101","volume":"14","author":"M Zwarenstein","year":"2009","unstructured":"Zwarenstein M, Treweek S. What kind of randomised trials do patients and clinicians need? Evid Based Med. 2009;14:101\u20133.","journal-title":"Evid Based Med"},{"key":"3987_CR50","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200\u20137.","journal-title":"Ann Intern Med"},{"key":"3987_CR51","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.2196\/jmir.1923","volume":"13","author":"G Eysenbach","year":"2011","unstructured":"Eysenbach G, CONSORT-EHEALTH Group. CONSORT-EHEALTH: Improving and Standardizing Evaluation Reports of Web-based and Mobile Health Interventions. J Med Internet Res. 2011;13:e126.","journal-title":"J Med Internet Res"},{"key":"3987_CR52","unstructured":"Optimune study web site. Hamburg: Gaia Group; 2018. https:\/\/optimune-studie.de."},{"key":"3987_CR53","unstructured":"Kuemmel S, Schmidt M. AGO Guidelines Breast Version 2016.1D: Komplement\u00e4re Therapien Hormontherapie \u201eSurvivorship\u201c (Rezidiv-Pr\u00e4vention). 2016. https:\/\/www.ago-online.de\/fileadmin\/downloads\/leitlinien\/mamma\/Maerz2016\/de\/2016D%2024_Komplementaere%20Therapie.pdf.\u00a0Accessed 20 May 2019."},{"key":"3987_CR54","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.4055","volume":"17","author":"L Yardley","year":"2015","unstructured":"Yardley L, Morrison L, Bradbury K, Muller I. The person-based approach to intervention development: application to digital health-related behavior change interventions. J Med Internet Res. 2015;17:e30.","journal-title":"J Med Internet Res"},{"key":"3987_CR55","doi-asserted-by":"publisher","DOI":"10.1037\/10488-000","volume-title":"Stress management intervention for women with breast cancer","author":"MH Antoni","year":"2003","unstructured":"Antoni MH. Stress management intervention for women with breast cancer. Washington, DC: American Psychological Association; 2003. https:\/\/doi.org\/10.1037\/10488-000."},{"key":"3987_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112733","volume":"9","author":"P Kvillemo","year":"2014","unstructured":"Kvillemo P, Br\u00e4nstr\u00f6m R. Coping with breast cancer: a meta-analysis. PLOS One. 2014;9:e112733.","journal-title":"PLOS One"},{"issue":"Pt A","key":"3987_CR57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cct.2015.07.016","volume":"45","author":"V Vickerstaff","year":"2015","unstructured":"Vickerstaff V, Ambler G, King M, Nazareth I, Omar RZ. Are multiple primary outcomes analysed appropriately in randomised controlled trials? A review. Contemp Clin Trials. 2015;45(Pt A):8\u201312.","journal-title":"Contemp Clin Trials"},{"key":"3987_CR58","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1017\/S0033291798006667","volume":"28","author":"The WHOQOL Group","year":"1998","unstructured":"The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychol Med. 1998;28:551\u20138.","journal-title":"Psychol Med"},{"key":"3987_CR59","unstructured":"World Health Organization. WHOQOL-BREF : introduction, administration, scoring and generic version of the assessment : field trial version, December 1996. Geneva: WHO; 1996. https:\/\/apps.who.int\/iris\/handle\/10665\/63529?show=full. Accessed 12 Feb 2019."},{"key":"3987_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","volume":"13","author":"SM Skevington","year":"2004","unstructured":"Skevington SM, Lotfy M, O\u2019Connell KA. The World Health Organization\u2019s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A Report from the WHOQOL Group. Qual Life Res. 2004;13:299\u2013310.","journal-title":"Qual Life Res"},{"key":"3987_CR61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1479-5868-8-115","volume":"8","author":"PH Lee","year":"2011","unstructured":"Lee PH, Macfarlane DJ, Lam T, Stewart SM. Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act. 2011;8:115.","journal-title":"Int J Behav Nutr Phys Act"},{"key":"3987_CR62","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","volume":"85","author":"TR Mendoza","year":"1999","unstructured":"Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, et al. The rapid assessment of fatigue severity in cancer patients. Cancer. 1999;85:1186\u201396.","journal-title":"Cancer."},{"key":"3987_CR63","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0885-3924(03)00073-3","volume":"25","author":"L Radbruch","year":"2003","unstructured":"Radbruch L, Sabatowski R, Elsner F, Everts J, Mendoza T, Cleeland C. Validation of the German version of the Brief Fatigue Inventory. J Pain Symptom Manag. 2003;25:449\u201358.","journal-title":"J Pain Symptom Manag"},{"key":"3987_CR64","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.brat.2003.07.010","volume":"41","author":"M Creamer","year":"2003","unstructured":"Creamer M, Bell R, Failla S. Psychometric properties of the Impact of Event Scale-Revised. Behav Res Ther. 2003;41:1489\u201396.","journal-title":"Behav Res Ther"},{"key":"3987_CR65","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3928\/0048-5713-20020901-06","volume":"32","author":"K Kroenke","year":"2002","unstructured":"Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32:509\u201315.","journal-title":"Psychiatr Ann"},{"key":"3987_CR66","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606\u201313.","journal-title":"J Gen Intern Med"},{"key":"3987_CR67","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","volume":"46","author":"B L\u00f6we","year":"2008","unstructured":"L\u00f6we B, Decker O, M\u00fcller S, Br\u00e4hler E, Schellberg D, Herzog W, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46:266\u201374.","journal-title":"Med Care"},{"key":"3987_CR68","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092\u20137.","journal-title":"Arch Intern Med"},{"key":"3987_CR69","unstructured":"Herschbach P, Berg P, Engst-Hastreiter U, Waadt S, Duran G, Henrich G. Entwicklung und Evaluation eines Therapieprogramms zur Bew\u00e4ltigung von Progredienzangst. Munich: Klinik und Poliklinik f\u00fcr Psychosomatische Medizin und Psychotherapie, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen; 2006."},{"key":"3987_CR70","volume-title":"Diagnostik von Progredienzangst \u2013 Entwicklung eines Fragebogens zur Erfassung von Progredienzangst bei Patienten mit Krebserkrankungen, Diabetes mellitus und entz\u00fcndlich-rheumatischen Erkrankungen in der Rehabilitation","author":"P Herschbach","year":"2001","unstructured":"Herschbach P, Dankert A, Duran-Atzinger G, Waadt S, Engst-Hastreiter U, Keller M, et al. Diagnostik von Progredienzangst \u2013 Entwicklung eines Fragebogens zur Erfassung von Progredienzangst bei Patienten mit Krebserkrankungen, Diabetes mellitus und entz\u00fcndlich-rheumatischen Erkrankungen in der Rehabilitation. Munich: Institut f\u00fcr Psychosomatische Medizin, medizinische Psychologie und Psychotherapie der TU-M\u00fcnchen; 2001."},{"key":"3987_CR71","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/sleep\/34.5.601","volume":"34","author":"CM Morin","year":"2011","unstructured":"Morin CM, Belleville G, B\u00e9langer L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34:601\u20138.","journal-title":"Sleep."},{"key":"3987_CR72","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1057\/dbm.2008.4","volume":"15","author":"TL Keiningham","year":"2008","unstructured":"Keiningham TL, Aksoy L, Cooil B, Andreassen TW, Williams L. A holistic examination of Net Promoter. J Database Mark Cust Strategy Manag. 2008;15:79\u201390.","journal-title":"J Database Mark Cust Strategy Manag"},{"key":"3987_CR73","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen J. A power primer. Psychol Bull. 1992;112:155\u20139.","journal-title":"Psychol Bull"},{"key":"3987_CR74","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/pon.1400","volume":"18","author":"D Ledesma","year":"2009","unstructured":"Ledesma D, Kumano H. Mindfulness-based stress reduction and cancer: a meta-analysis. Psycho-Oncology. 2009;18:571\u20139.","journal-title":"Psycho-Oncology."},{"key":"3987_CR75","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000330714","volume":"18","author":"F Musial","year":"2011","unstructured":"Musial F, B\u00fcssing A, Heusser P, Choi K-E, Ostermann T. Mindfulness-based stress reduction for integrative cancer care \u2014 a summary of evidence. Forschende Komplement\u00e4rmedizin\/Research in Complementary Medicine. 2011;18:192\u2013202.","journal-title":"Forschende Komplement\u00e4rmedizin\/Research in Complementary Medicine"},{"key":"3987_CR76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10865-005-9036-1","volume":"29","author":"K Tatrow","year":"2006","unstructured":"Tatrow K, Montgomery GH. Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis. J Behav Med. 2006;29:17\u201327.","journal-title":"J Behav Med"},{"key":"3987_CR77","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/2229-3485.83221","volume":"2","author":"S Gupta","year":"2011","unstructured":"Gupta S. Intention-to-treat concept: a review. Perspectives Clin Res. 2011;2:109.","journal-title":"Perspectives Clin Res"},{"key":"3987_CR78","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1001\/jama.2015.15281","volume":"314","author":"P Li","year":"2015","unstructured":"Li P, Stuart EA, Allison DB. Multiple imputation: a flexible tool for handling missing data. JAMA. 2015;314:1966\u20137.","journal-title":"JAMA."},{"key":"3987_CR79","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials \u2014 a practical guide with flowcharts. BMC Med Res Methodol. 2017;17:162.","journal-title":"BMC Med Res Methodol"},{"key":"3987_CR80","first-page":"1","volume":"8","author":"NS O\u2019Connell","year":"2017","unstructured":"O\u2019Connell NS, Dai L, Jiang Y, Speiser JL, Ward R, Wei W, et al. Methods for analysis of pre-post data in clinical research: a comparison of five common methods. J Biom Biostat. 2017;8:1\u20138.","journal-title":"J Biom Biostat"},{"key":"3987_CR81","volume-title":"ICH E9 statistical principles for clinical trials","author":"EMEA","year":"1998","unstructured":"EMEA. ICH E9 statistical principles for clinical trials. London: European Medicines Agency; 1998."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3987-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3987-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3987-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T21:04:41Z","timestamp":1722373481000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3987-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3987"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3987-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]},"assertion":[{"value":"24 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This trial has been approved by the research ethics committee of the Leibniz Research Centre for Working Environment and Human Factors. The study was registered at ClinicalTrials.gov, NCT03643640 (ClinicalTrials.gov) on 23 August 2018. Protocol amendments will be posted on ClinicalTrials.gov and communicated with the ethics committee. All trial participants will provide online informed consent before initiating any further study-related procedure. All procedures performed in the study involving human participants are in accordance with the ethical standards of the ethics committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BM, MW and FH are affiliated with Gaia, the e-Health company that funds this trial and that developed, owns and operates the Internet intervention that the trial evaluates. MW is Chief Executive Officer and founder of Gaia, BM is employed full-time as research director and FH is employed full-time as research associate. The other authors (AM and CW) declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}